Skip to Main Content.
Site navigation
Fidelity.com Home
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
  • Accounts & Trade
    • Portfolio Log In Required
    • Portfolio
    • AccountPositions Log In Required
    • AccountPositions
    • Trade Log In Required
    • Trade
    • Trading Dashboard Log In Required
    • Trading Dashboard Log In Required
    • Active Trader Pro
    • Transfers
    • Cash Management Log In Required
    • Cash Management
    • Bill Pay Log In Required
    • Bill Pay
    • Full View Log In Required
    • Full View
    • Security Settings Log In Required
    • Security Settings
    • Account Features Log In Required
    • Account Features
    • Statements Log In Required
    • Statements
    • Fidelity Alternative Investments Program Log In Required
    • Tax Forms & Information
    • Retirement Distributions Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • Fidelity Rewards+registered trademark Log In Required
    • New Account Checklist Log In Required
    • Lending Solutions-Line of Credit Log In Required
    • Refer a Friend
  • Planning & Advice
    • What We Offer
    • Build Your Plan
    • My Goals
    • Financial Basics
    • Building Savings
    • Robo Investing Plus Financial Advice
    • Wealth Management
    • Find an advisor
    • Retirement
    • Life Events
    • Saving & Investing for a Child
    • Charitable Giving
    • Philanthropic Consulting
  • News & Research
    • News
    • Wealth Management Insights
    • Watch List Log In Required
    • Quotes
    • Quotes
    • Alerts Log In Required
    • Mutual Funds
    • Stocks
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Markets & Sectors
    • IPOs
    • Annuities
    • Learning Center
    • Notebook
    • Notebook
  • Investment Products
    • Mutual Funds
    • Retirement & IRAs
    • Stocks and Trading
    • Crypto
    • Direct Indexing
    • Fixed Income, Bonds & CDs
    • ETFs
    • Options
    • Sustainable Investing
    • Cash Management & Credit Cards
    • Managed Accounts
    • 529 College Savings
    • Health Savings Accounts
    • Annuities
    • Life Insurance & Long Term Care
  • Why Fidelity
    • The Fidelity Advantage
    • Planning & Advice
    • Trading
    • Straightforward Pricing
    • Insights & Tools
    • Security & Protection
    • Marketplace Solutions
    • About Fidelity
    • Careers
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log In
  • Customer Service
  • Profile
  • Open an Account
  • Virtual Assistant
  • Log Out
Content and data provided by various third parties and Fidelity − Terms of Use
  • Research >
  • Stocks >
  • News & Events >

Stock Details


  • Snapshot
  • Detailed Quote
  • Advanced Chart &
    Technical Analysis Opens in New Window
  • News & Events
  • Compare
  • Analyst Opinions
  • Research Reports
  • Key Statistics
  • Earnings
  • Dividends
  • Ownership & Insiders
  • Financial Statements
  • SEC Filings

RELATED RESOURCES

  • Stock Research Overview
  • Stock Screeners
  • Markets & Sectors
  • Fidelity Learning Center Opens in New Window
Print Format
Change Text Size:
  • Default text sizeA
  • Larger text sizeA
  • Largest text sizeA

89 Biggest Movers From Friday

BY Benzinga
— 4:44 AM ET 06/21/2022

Gainers

  • Revlon, Inc. NYSE:REV jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
  • Grove Collaborative Holdings, Inc. NYSE:GROV rose 67.9% to close at $10.00. Grove Collaborative and Virgin Group Acquisition Corp. II announced the completion of their previously announced business combination.
  • Mereo BioPharma Group plc NASDAQ:MREO gained 62.5% to close at $1.30. AstraZeneca is rumored to be eyeing takeover of Mereo BioPharma Group, according to a report in The Times.
  • SoundHound AI, Inc. NASDAQ:SOUN climbed 49.8% to close at $4.44.
  • Swvl Holdings Corp. NASDAQ:SWVL gained 35.3% to settle at $6.90.
  • Clovis Oncology, Inc. NASDAQ:CLVS surged 31.9% to close at $1.18. Clovis Oncology recently announced a presentation detailing initial Phase 1 data from Phase 1/2 LuMIERE clinical study of FAP-2286 labeled with lutetium-177 (177Lu-FAP-2286).
  • Jupiter Wellness, Inc. NASDAQ:JUPW jumped 31.4% to close at $0.80. Jupiter Wellness retired approximately 10% of its outstanding shares.
  • Satellogic Inc. NASDAQ:SATL jumped 29.6% to close at $5.04.
  • Electric Last Mile Solutions, Inc. NASDAQ:ELMS gained 29.4% to close at $0.3650 after jumping 100% on Thursday.
  • Sesen Bio, Inc. NASDAQ:SESN climbed 29.2% to close at $0.76.
  • Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP jumped 28.8% to close at $0.3002.
  • Virgin Orbit Holdings, Inc. NASDAQ:VORB gained 28.1% to close at $3.51.
  • Cipher Mining Inc. NASDAQ:CIFR gained 27.3% to settle at $1.82.
  • Comera Life Sciences Holdings, Inc. NASDAQ:CMRA gained 26.9% to close at $4.44. Comera was granted U.S. patent titled 'Excipient compounds for protein processing.'
  • Clear Channel Outdoor Holdings, Inc. NYSE:CCO jumped 26.6% to settle at $1.38.
  • Tivic Health Systems, Inc. NASDAQ:TIVC rose 26.3% to close at $2.40. Tivic Health Systems, during May, reported a Q1 loss of $0.23 per share.
  • Starry Group Holdings, Inc. NYSE:STRY gained 26% to close at $5.18. Cowen & Co. initiated coverage on Starry Group Holdings with an Outperform rating and announced a price target of $9.
  • XpresSpa Group, Inc. NASDAQ:XSPA gained 24.6% to close at $0.86.
  • Secoo Holding Limited NASDAQ:SECO rose 24% to settle at $0.2874. Secoo received approval to transfer to Nasdaq Capital Market.
  • Symbotic Inc. NASDAQ:SYM gained 23.8% to close at $16.80.
  • Altimmune, Inc. NASDAQ:ALT surged 22.9% to settle at $9.02.
  • Pharvaris N.V. NASDAQ:PHVS jumped 22.1% to close at $27.50.
  • Virco Mfg. Corporation NASDAQ:VIRC gained 21.9% to close at $3.67.
  • MINISO Group Holding Limited NYSE:MNSO climbed 21.8% to close at $7.67.
  • Sana Biotechnology, Inc. NASDAQ:SANA gained 21.5% to close at $5.15.
  • Jerash Holdings US, Inc. NASDAQ:JRSH jumped 20.2% to settle at $6.70. Jerash Holdings' board recently authorized a $3 million buyback.
  • Crexendo, Inc. NASDAQ:CXDO surged 20.1% to settle at $3.23.
  • Lyell Immunopharma, Inc. NASDAQ:LYEL jumped 20% to close at $5.46.
  • PhaseBio Pharmaceuticals, Inc. NASDAQ:PHAS rose 19.8% to close at $0.6201.
  • Zai Lab Limited NASDAQ:ZLAB jumped 19.8% to close at $27.73. Zai Lab recently announced breakthrough therapy designations granted for Repotrectinib in China.
  • Rocky Mountain Chocolate Factory, Inc. NASDAQ:RMCF jumped 19.6% to settle at $8.25. Rocky Mountain Chocolate, last month, posted Q4 EPS of $0.01.
  • Centessa Pharmaceuticals plc NASDAQ:CNTA gained 19.1% to close at $4.93 after BRMO Capital initiated coverage on the stock with an Outperform rating and $19 price target.
  • Sonder Holdings Inc. NASDAQ:SOND surged 18.8% to close at $1.52.
  • Helbiz, Inc. NASDAQ:HLBZ climbed 18.6% to close at $0.83.
  • REE Automotive Ltd. NASDAQ:REE jumped 18.6% to close at $1.53.
  • Rubius Therapeutics, Inc. NASDAQ:RUBY gained 18.4% to settle at $0.9323.
  • Lilium N.V. NASDAQ:LILM gained 18% to close at $2.69.
  • Heritage Global Inc. NASDAQ:HGBL jumped 17.8% to close at $1.55.
  • Cogent Biosciences, Inc. NASDAQ:COGT jumped 17.8% to close at $9.19. Cogent Biosciences recently announced a proposed public offering of $125 million of common stock.
  • Q&K International Group Limited NASDAQ:QK gained 17.7% to settle at $1.60.
  • Velocity Financial, Inc. NYSE:VEL rose 17.6% to close at $11.64.
  • BridgeBio Pharma, Inc. NASDAQ:BBIO gained 17.5% to close at $7.65.
  • Mersana Therapeutics, Inc. NASDAQ:MRSN jumped 17.5% to close at $3.70.
  • Akero Therapeutics, Inc. NASDAQ:AKRO surged 17.3% to settle at $12.16. Akero Therapeutics announced a $25 million equity investment by Pfizer at $9.90 per share.
  • Quotient Limited NASDAQ:QTNT gained 17.2% to settle at $0.3599.
  • Dyne Therapeutics, Inc. NASDAQ:DYN rose 17.2% to close at $5.94.
  • Synlogic, Inc. NASDAQ:SYBX surged 16.6% to close at $1.04.
  • Bit Digital, Inc. NASDAQ:BTBT jumped 16.4% to close at $1.42.
  • Allogene Therapeutics, Inc. NASDAQ:ALLO gained 16.4% to close at $ 10.96.
  • Allogene Therapeutics recently said that the FDA granted regenerative medicine advanced therapy designation to ALLO-501A for Large B Cell Lymphoma.
  • Stem, Inc. NYSE:STEM rose 16.4% to settle at $7.30.
  • bluebird bio, Inc. NASDAQ:BLUE shares gained 16.3% to close at $3.56. The FDA's Advisory Committee recently unanimously backed Bluebird bio's gene therapy for a rare blood disorder.
  • Atara Biotherapeutics, Inc. NASDAQ:ATRA rose 16.2% to close at $5.87.
  • Scopus BioPharma Inc. NASDAQ:SCPS jumped 15.9% to settle at $0.4250.
  • Vaxart, Inc. NASDAQ:VXRT gained 15.6% to close at $3.12.
  • Recursion Pharmaceuticals, Inc. NASDAQ:RXRX jumped 15.3% to close at $7.62.
  • Allakos Inc. NASDAQ:ALLK gained 14.2% to close at $2.97.
  • Kinnate Biopharma Inc. NASDAQ:KNTE rose 13.7% to close at $9.36.
  • Seagen Inc. NASDAQ:SGEN shares rose 12.7% to close at $165.45. Merck is eyeing purchase of biotech Seagen, while other unnamed suitors are also eyeing Seagen, the Wall Street Journal said.
  • Calliditas Therapeutics AB NASDAQ:CALT rose 12% to close at $17.82.
  • Scholar Rock Holding Corporation NASDAQ:SRRK shares rose 10.9% to close at $5.39. Scholar Rock reported Phase 2 topaz trial extension data showing 'sizable and sustained motor function improvement at 24 months with apitegromab for non-ambulatory patients with types 2 and 3 spinal muscular atrophy.'
  • Sapiens International Corporation N.V. NASDAQ:SPNS climbed 10.9% to close at $23.22.
  • Sight Sciences, Inc. NASDAQ:SGHT jumped 10.4% to close at $8.27.
  • Surrozen, Inc. NASDAQ:SRZN gained 8.6% to close at $2.41. Surrozen recently initiated dosing in Phase 1 clinical trial of SZN-043 for severe alcoholic hepatitis.

 


Losers

  • Renovare Environmental, Inc NASDAQ:RENO fell 64.7% to close at $0.06 on Friday.
  • Addex Therapeutics Ltd NASDAQ:ADXN shares declined 58.3% to settle at $1.50 after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's disease due to slow recruitment. The company suspended its guidance amid the termination.
  • ToughBuilt Industries, Inc. NASDAQ:TBLT fell 51.5% to close at $1.48 after the company priced a $6 million offering.
  • Advent Technologies Holdings, Inc. NASDAQ:ADN declined 27.6% to close at $2.89. Advent Technologies recently announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
  • Bon Natural Life Limited NASDAQ:BON fell 23% to close at $2.85.
  • Axcella Health Inc. NASDAQ:AXLA dropped 22.7% to close at $1.80.
  • Pennsylvania Real Estate Investment Trust NYSE:PEI shares declined 20.5% to close at $4.23.
  • Sidus Space, Inc. NASDAQ:SIDU fell 19.3% to close at $6.16.
  • Equillium, Inc. NASDAQ:EQ declined 16.7% to settle at $1.75.
  • NeuroPace, Inc.NASDAQ:NPCE fell 16% to close at $5.03.
  • Tabula Rasa HealthCare, Inc. NASDAQ:TRHC dropped 15.7% to close at $2.42.
  • Innate Pharma S.A. NASDAQ:IPHA fell 15.3% to close at $2.00.
  • Applied UV, Inc. NASDAQ:AUVI declined 15.2% to close at $2.45.
  • AN2 Therapeutics, Inc. NASDAQ:ANTX fell 15.1% to settle at $8.51.
  • Neptune Wellness Solutions Inc. NASDAQ:NEPT declined 14.7% to close at $2.32. Neptune Wellness appointed Raymond Silcock as Chief Financial Officer.
  • Vertex Energy, Inc. NASDAQ:VTNR fell 14.5% to settle at $11.82.
  • Mesa Royalty Trust NYSE:MTR declined 14.5% to close at $14.96.
  • Northern Oil and Gas, Inc. NYSE:NOG fell 14.4% to close at $27.52.
  • Hillstream BioPharma, Inc. NASDAQ:HILS dropped 14.4% to close at $0.78.
  • Alvotech Ordinary Shares NASDAQ:ALVO fell 14.1% to close at $9.70.
  • Heart Test Laboratories, Inc. NASDAQ:HSCS dropped 14.1% to close at $2.0777. Heart Test Laboratories announced pricing of its IPO of 1.5 million units at a price of $4.25 per unit.
  • Athersys, Inc. NASDAQ:ATHX fell 12.9% to close at $0.2789 after dropping more than 12% on Thursday.
  • Calumet Specialty Products Partners, L.P. NASDAQ:CLMT declined 12.1% to close at $10.15.
  • Vivakor, Inc. NASDAQ:VIVK fell 10.4% to close at $2.23. Vivakor shares jumped 40% on Thursday after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
  • Dream Finders Homes, Inc. NASDAQ:DFH dipped 10% to close at $10.64. B of A Securities downgraded Dream Finders Homes from Neutral to Underperform and lowered the price target from $18 to $10.5.
  • Range Resources Corporation NYSE:RRC fell 9.9% to close at $26.29.

More VXRT News

  • Vaxart to Host Investor Q&A Webcast
    GlobeNewswire - 4:05 PM ET 06/16/2022
  • BRIEF-Vaxart Announces Adjournment Of Annual Meeting Of Stockholders
    Reuters - 9:12 AM ET 06/08/2022
  • Vaxart Announces Adjournment of Annual Meeting of Stockholders
    GlobeNewswire - 9:05 AM ET 06/08/2022
Fidelity Investments. Copyright 1998–2022 FMR LLC. 
All rights reserved. 

  • Terms of Use|
  • Privacy|
  • Security|
  • Site Map 
Close